These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 23391271

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V, Elewaut D, Bougarne N, Bracke D, Van Calenbergh S, Haegeman G, De Bosscher K.
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [Abstract] [Full Text] [Related]

  • 23. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance.
    Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E.
    Hormones (Athens); 2016 Jun; 15(1):23-34. PubMed ID: 27086682
    [Abstract] [Full Text] [Related]

  • 27. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
    Machuca C, Mendoza-Milla C, Córdova E, Mejía S, Covarrubias L, Ventura J, Zentella A.
    BMC Cell Biol; 2006 Feb 21; 7():9. PubMed ID: 16504042
    [Abstract] [Full Text] [Related]

  • 28. A NOVEL GLUCOCORTICOID RECEPTOR MUTATION IN PRIMARY GENERALIZED GLUCOCORTICOID RESISTANCE DISEASE.
    Ma L, Tan X, Li J, Long Y, Xiao Z, De J, Ren Y, Tian H, Chen T.
    Endocr Pract; 2020 Jun 02; 26(6):651-659. PubMed ID: 32045292
    [Abstract] [Full Text] [Related]

  • 29. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation.
    Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP.
    Proc Assoc Am Physicians; 1996 Jul 02; 108(4):296-307. PubMed ID: 8863343
    [Abstract] [Full Text] [Related]

  • 30. Functional analysis of the LXXLL motifs of the human glucocorticoid receptor: association with altered ligand affinity.
    Dong DD, Jewell CM, Bienstock RJ, Cidlowski JA.
    J Steroid Biochem Mol Biol; 2006 Oct 02; 101(2-3):106-17. PubMed ID: 16914312
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.
    Donner KM, Hiltunen TP, Jänne OA, Sane T, Kontula K.
    Eur J Endocrinol; 2013 Jan 02; 168(1):K9-K18. PubMed ID: 23076843
    [Abstract] [Full Text] [Related]

  • 33. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells.
    Ray DW, Davis JR, White A, Clark AJ.
    Cancer Res; 1996 Jul 15; 56(14):3276-80. PubMed ID: 8764121
    [Abstract] [Full Text] [Related]

  • 34. Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment.
    Avenant C, Kotitschke A, Hapgood JP.
    Biochemistry; 2010 Feb 09; 49(5):972-85. PubMed ID: 20047289
    [Abstract] [Full Text] [Related]

  • 35. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R.
    Cancer Res; 1996 Nov 01; 56(21):5033-8. PubMed ID: 8895760
    [Abstract] [Full Text] [Related]

  • 36. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP.
    J Clin Endocrinol Metab; 2001 Nov 01; 86(11):5600-8. PubMed ID: 11701741
    [Abstract] [Full Text] [Related]

  • 37. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
    Zhao Q, Pang J, Favata MF, Trzaskos JM.
    Int Immunopharmacol; 2003 Dec 01; 3(13-14):1803-17. PubMed ID: 14636830
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A rapid interference between glucocorticoids and cAMP-activated signalling in hypothalamic neurones prevents binding of phosphorylated cAMP response element binding protein and glucocorticoid receptor at the CRE-Like and composite GRE sites of thyrotrophin-releasing hormone gene promoter.
    Díaz-Gallardo MY, Cote-Vélez A, Charli JL, Joseph-Bravo P.
    J Neuroendocrinol; 2010 Apr 01; 22(4):282-93. PubMed ID: 20136691
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
    Gougat C, Jaffuel D, Gagliardo R, Henriquet C, Bousquet J, Demoly P, Mathieu M.
    J Mol Med (Berl); 2002 May 01; 80(5):309-18. PubMed ID: 12021843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.